患者の期待をよりよく理解するために:ONCOPREMs-1研究 - 定性研究
Loubna Diouri1,2, Fiona Ecarnot3,4, Sophie Berjot5
1IRMAIC, Université Reims Champagne Ardenne, 51 Rue Cognacq Jay, 51100, Reims, France. Loubna.diouri@reims.unicancer.fr.
Aging clinical and experimental research
|August 26, 2025
まとめ
この研究では 癌患者の経験を調査し 治療の経路が期待に応えたことがわかりました 患者さんは 介護者に より多くの支援を望んでおり 腫瘍学における改善の鍵となる領域を 強調しています
科学分野:
- 腫瘍学
- 患者体験調査
- 質的健康研究
背景:
- OncoPREMsの研究の一環として 患者体験評価ツールを開発しました
- 初期症状から生存まで 患者の知覚を調べました
- がん患者の体験に 焦点を当てています
研究 の 目的:
- 患者さんの期待と経験を 癌治療の全過程で理解することです
- 患者の腫瘍治療に対する認識の鍵となるテーマを特定する.
- 患者中心の腫瘍ケアツールの開発を促す
主な方法:
- 半構造面接を用いた定性研究
- フランスで28人のがん患者 (14人の男性,14人の女性) を対象に実施された.
- 面接データのテーマ分析
主要な成果:
- 診断,治療,がん後の生存
- 乳がん,消化器がん,泌尿器がんなど
- 患者の経験は概して期待値と一致した.
結論:
- がん治療の経路は 患者のニーズと期待に大きく応えています
- 患者は介護者の支援と指導の必要性を強調した.
- 結果は腫瘍学における患者と介護者のサポートの改善を報告する.
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Guidelines for Writing Outcome
3.0K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.0K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453


